---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-24-000110"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T18:46:33.729074+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q1 revenue up 7.7% to $717.4M, Adjusted EBITDA $97.5M; raises FY outlook

## Summary
- Net loss $12.4M; Adjusted EBITDA $97.5M (+8.2% YoY); margin 13.6%.
- Same-facility revenue +10.2% YoY with 8.8% revenue per case increase and 1.3% case growth.
- FY 2024 guidance raised: revenue at least $3.05B, Adjusted EBITDA at least $505M.
- Completed refinancing of term loan and unsecured notes; no material debt maturities until 2030.
- Cash $185.2M; revolver capacity $607.3M; net debt/EBITDA ratio ~3.5x.

## SEC filing metadata
- accession: 0001638833-24-000110
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/sgry-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-24-000110
- JSON: https://secwatch.observer/filing/0001638833-24-000110.json
- Plain text: https://secwatch.observer/filing/0001638833-24-000110.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported full year 2024 results: revenue at least $3.05 billion. Guidance raised.
  - Period: full year 2024
  - Revenue: at least $3.05 billion
  - Guidance: raised
  - Result: guidance update
  source text: The Company raised its outlook for 2024 revenues to be at least $3.05 billion and projects 2024 Adjusted EBITDA to be at least $505 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported three months ended March 31, 2024 results: revenue $717.4 million, net income -$12.4 million.
  - Period: three months ended March 31, 2024
  - Revenue: $717.4 million
  - Net income: -$12.4 million
  - Result: reported results
  source text: • Revenues increased 7.7% to $717.4 million compared to the prior year period ◦ Same-facility revenues increased 10.2% • Net loss attributable to Surgery Partners, Inc. was $12.4 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.